Type i IFN induced IL1-Ra expression in hepatocytes is mediated by activating STAT6 through the formation of STAT2: STAT6 heterodimer

Journal of Cellular and Molecular Medicine

Volumn 12, Issue 3, 2008, Pages 876-888

  Wan, Lei ^a,b,c   Lin, Cheng Wen ^b   Lin, Ying Ju ^b,c   Sheu, Jim J C ^a,b   Chen, Bing Hung ^d   Liao, Chiu Chu ^a   Tsai, Yuhsin ^b   Lin, Wei Yong ^a   Lai, Chih Ho ^e   Tsai, Fuu Jen ^a,b,c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

IL 1Ra; STAT2; STAT6; Type I interferon

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; IL1RN PROTEIN, HUMAN; INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; STAT2 PROTEIN; STAT6 PROTEIN; STAT6 PROTEIN, HUMAN;

ARTICLE; BIOLOGICAL MODEL; BIOSYNTHESIS; DIMERIZATION; DRUG EFFECT; GENETICS; HUMAN; LIVER CELL; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DIMERIZATION; HEPATOCYTES; HUMANS; INTERFERON TYPE I; INTERFERON-ALPHA; INTERFERON-BETA; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LIVER NEOPLASMS; MODELS, BIOLOGICAL; PHOSPHORYLATION; STAT2 TRANSCRIPTION FACTOR; STAT6 TRANSCRIPTION FACTOR;

EID: 44149111595     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00143.x     Document Type: Article

References (41)

1. Pfeffer LM, Dinarello CA, Herberman RB, Williams BR, Borden EC, Bordens R, Walter MR, Nagabhushan TL, Trotta PP, Pestka S. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res. 1998 58 : 2489 99.
2. Caraglia M, Marra M, Pelaia G, Maselli R, Caputi M, Marsico SA, Abbruzzese A. Alpha-interferon and its effects on signal transduction pathways. J Cell Physiol. 2005 202 : 323 35.
3. Moriyama M, Arakawa Y. Treatment of interferon-alpha for chronic hepatitis C. Expert Opin Pharmacother. 2006 7 : 1163 79.
4. Tagliaferri P, Caraglia M, Budillon A, Marra M, Vitale G, Viscomi C, Masciari S, Tassone P, Abbruzzese A, Venuta S. New pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-alpha) treatment of human cancer. Cancer Immunol Immunother. 2005 54 : 1 10.
5. Eggermont AM. Current status of interferon-alpha in the treatment of melanoma. Cancer Chemother Biol Response Modif. 2005 22 : 729 37.
6. Caraglia M, Vitale G, Marra M, Budillon A, Tagliaferri P, Abbruzzese A. Alpha-interferon and its effects on signaling pathways within cells. Curr Protein Pept Sci. 2004 5 : 475 85.
7. Domanski P, Fish E, Nadeau OW, Witte M, Platanias LC, Yan H, Krolewski J, Pitha P, Colamonici OR. A region of the beta subunit of the interferon alpha receptor different from box 1 interacts with Jak1 and is sufficient to activate the Jak-Stat pathway and induce an antiviral state. J Biol Chem. 1997 272 : 26388 93.
8. Colamonici O, Yan H, Domanski P, Handa R, Smalley D, Mullersman J, Witte M, Krishnan K, Krolewski J. Direct binding to and tyrosine phospho-rylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase. Mol Cell Biol. 1994 14 : 8133 42.
9. Novick D, Cohen B, Rubinstein M. The human interferon alpha-beta receptor: characterization and molecular cloning. Cell. 1994 77 : 391 400.
10. Wurster AL, Tanaka T, Grusby MJ. The biology of Stat4 and Stat6. Oncogene. 2000 19 : 2577 84.
11. Gupta S, Jiang M, Pernis AB. IFN-alpha activates Stat6 and leads to the formation of Stat2: Stat6 complexes in B cells. J Immunol. 1999 163 : 3834 41.
12. Fasler-Kan E, Pansky A, Wiederkehr M, Battegay M, Heim MH. Interferon-alpha activates signal transducers and activators of transcription 5 and 6 in Daudi cells. Eur J Biochem. 1998 254 : 514 9.
13. Eriksen KW, Sommer VH, Woetmann A, Rasmussen AB, Brender C, Svejgaard A, Skov S, Geisler C, Odum N. Bi-phasic effect of interferon (IFN)-alpha: IFN-alpha up- and down-regulates interleukin-4 signaling in human T cells. J Biol Chem. 2004 279 : 169 76.
14. Leonard WJ. Role of Jak kinases and STATs in cytokine signal transduction. Int J Hematol. 2001 73 : 271 7.
15. Kotenko SV, Pestka S. Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes. Oncogene. 2000 19 : 2557 65.
16. Ariyasu T, Tanaka T, Fujioka N, Yanai Y, Yamamoto S, Yamauchi H, Ikegami H, Ikeda M, Kurimoto M. Effects of interferon-alpha subtypes on the TH1-TH2 balance in peripheral blood mononuclear cells from patients with hepatitis virus infection-associated liver disorders. In Vitro Cell Dev Biol Anim. 2005 41 : 50 6.
17. Feng J, Misu T, Fujihara K, Misawa N, Koyanagi Y, Shiga Y, Takeda A, Sato S, Takase S, Kohnosu T, Saito H, Itoyama Y. Th1-Th2 balance and HTLV-I proviral load in HAM-TSP patients treated with interferon-alpha. J Neuroimmunol. 2004 151 : 189 94.
18. Hempel G, Galle PR, Lohr HF. Quantitative analysis of specific Th1-Th2 helper cell responses and IgG subtype antibodies in interferon-alpha-treated patients with chronic hepatitis C. J Med Virol. 2001 64 : 340 9.
19. Coclet-Ninin J, Dayer JM, Burger D. Interferon-beta not only inhibits interleukin-1beta and tumor necrosis factor-alpha but stimulates interleukin-1 receptor antagonist production in human peripheral blood mononuclear cells. Eur Cytokine Netw. 1997 8 : 345 9.
20. Huang Y, Blatt LM, Taylor MW. Type 1 interferon as an antiinflammatory agent: inhibition of lipopolysaccharide-induced interleukin-1 beta and induction of interleukin-1 receptor antagonist. J Interferon Cytokine Res. 1995 15 : 317 21.
21. Cotler SJ, Craft T, Ferris M, Morrisey M, McCone J, Reddy KR, Conrad A, Jensen DM, Albrecht J, Taylor MW. Induction of IL-1Ra in resistant and responsive hepatitis C patients following treatment with IFN-con1. J Interferon Cytokine Res. 2002 22 : 549 54.
22. Ohno Y, Fujimoto M, Nishimura A, Aoki N. Change of peripheral levels of pituitary hormones and cytokines after injection of interferon (IFN)-beta in patients with chronic hepatitis C. J Clin Endocrinol Metab. 1998 83 : 3681 7.
23. Naveau S, Emilie D, Borotto E, Portier A, Lazizi Y, Giraud V, Grangeot-Keros L, Capron F, Galanaud P, Chaput JC. Interleukin-1 receptor antagonist plasma concentration is specifically increased by alpha-2A-interferon treatment. J Hepatol. 1997 27 : 272 5.
24. Dinarello CA. Induction of interleukin-1 and inter-leukin-1 receptor antagonist. Semin Oncol. 1997 24 : S9-81 93.
25. Arend WP, Gabay C. Physiologic role of interleukin-1 receptor antagonist. Arthritis Res. 2000 2 : 245 8.
26. Gabay C, Gigley J, Sipe J, Arend WP, Fantuzzi G. Production of IL-1 receptor antagonist by hepatocytes is regulated as an acute-phase protein in vivo. Eur J Immunol. 2001 31 : 490 9.
27. Weinmann AS, Farnham PJ. Identification of unknown target genes of human transcription factors using chromatin immunoprecipitation. Methods. 2002 26 : 37 47.
28. Schroder AJ, Pavlidis P, Arimura A, Capece D, Rothman PB. Cutting edge: STAT6 serves as a positive and negative regulator of gene expression in IL-4-stimulated B lymphocytes. J Immunol. 2002 168 : 996 1000.
29. Kraus J, Borner C, Hollt V. Distinct palindromic extensions of the 5'-TTC...GAA-3'motif allow STAT6 binding in vivo. FASEB J. 2003 17 : 304 6.
30. Hebenstreit D, Wirnsberger G, Horejs-Hoeck J, Duschl A. Signaling mechanisms, interaction partners, and target genes of STAT6. Cytokine Growth Factor Rev. 2006 17 : 173 88.
31. Gabay C, Porter B, Guenette D, Billir B, Arend WP. Interleukin-4 (IL-4) and IL-13 enhance the effect of IL-1beta on production of IL-1 receptor antagonist by human primary hepatocytes and hepatoma HepG2 cells: differential effect on C-reactive protein production. Blood. 1999 93 : 1299 307.
32. So EY, Park HH, Lee CE. IFN-gamma and IFN-alpha posttranscriptionally down-regulate the IL-4-induced IL-4 receptor gene expression. J Immunol. 2000 165 : 5472 9.
33. Crow AR, Song S, Semple JW, Freedman J, Lazarus AH. A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg? Blood. 2007 109 : 155 8.
34. Ohmori Y, Smith MF Jr., Hamilton TA. IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6. J Immunol. 1996 157 : 2058 65.
35. Day RM, Soon L, Breckenridge D, Bridges B, Patel BK, Wang LM, Corey SJ, Bottaro DP. Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways. Oncogene. 2002 21 : 2201 11.
36. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M, Schreiber RD. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell. 1996 84 : 431 42.
37. Horvath CM, Darnell JE Jr. The antiviral state induced by alpha interferon and gamma interferon requires transcriptionally active Stat1 protein. J Virol. 1996 70 : 647 50.
38. Park C, Li S, Cha E, Schindler C. Immune response in Stat2 knockout mice. Immunity. 2000 13 : 795 804.
39. Li X, Leung S, Kerr IM, Stark GR. Functional subdo-mains of STAT2 required for preassociation with the alpha interferon receptor and for signaling. Mol Cell Biol. 1997 17 : 2048 56.
40. Leung S, Qureshi SA, Kerr IM, Darnell JE Jr., Stark GR. Role of STAT2 in the alpha interferon signaling pathway. Mol Cell Biol. 1995 15 : 1312 7.
41. Qureshi SA, Leung S, Kerr IM, Stark GR, Darnell JE, Jr. Function of Stat2 protein in transcriptional activation by alpha interferon. Mol Cell Biol. 1996 16 : 288 93.